Chemical Compound
Budesonide 21-acetate
CAS Registry Number
51333-05-2
Primary Record
Budesonide 21-acetate
- In stock
- 5,740 g
- Purity
- 98.7 %
- CAS
- 51333-05-2
Compound Identifiers & Properties
- CAS
- 51333-05-2
- PubChem CID
- 13298228
- SMILES
- CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)COC(=O)C)C)O)C
- Canonical SMILES
- CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)COC(C)=O)O1
Names & Synonyms
- Budesonide 21-acetate
- 4AZ2VA5QDS
- Budesonide Impurity K
- 51333-05-2
- UNII-4AZ2VA5QDS
- Budesonide EP Impurity K
- Budesonide impurity K [EP]
- RefChem:1049328
- SCHEMBL7735898
- DTXSID70535536
- FA16965
- BUDESONIDE IMPURITY K [EP IMPURITY]
- J413.601B
- FT-0661089
- Budesonide EP Impurity K (Mixture of Epimer)
- 21-Acetoxy-11b-hydroxy-16a,17a-propylmethylenedioxpregna-1,4-diene-3,20-dione
- BUDESONIDE 21-ACETATE (EPIMERS) [USP IMPURITY]
- (11b,16a)-21-(Acetyloxy)-16,17-[butylidenebis(oxy)]-11-hydroxy-pregna-1,4-diene-3,20-dione
- 21-Acetoxy-11beta-hydroxy-16alpha,17alpha-propylmethylenedioxpregna-1,4-diene-3,20-dione
- (11beta,16alpha)-21-(Acetyloxy)-16,17-(butylidenebis(oxy))-11-hydroxypregna-1,4-diene-3,20-dione
- [2-[(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-9,13-dimethyl-16-oxo-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl] acetate
- 21-(Acetoxy)-16alpha,17alpha-(butylidenedioxy)-11beta-hydroxypregna-1,4-diene-3,20-dione
- 21-Acetoxy-11|A-hydroxy-16|A,17|A-propylmethylenedioxpregna-1,4-diene-3,20-dione
- 16alpha,17-((1RS)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione-21-acetate
- 16alpha,17-(Butylidenebisoxy)-11beta,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate
- 21-Acetoxy-11?-hydroxy-16?,17?-propylmethylenedioxpregna-1,4-diene-3,20-dione
- (11,16)-21-(Acetyloxy)-16,17-[butylidenebis(oxy)]-11-hydroxy-pregna-1,4-diene-3,20-dione
- (11.BETA.,16.ALPHA.)-21-(ACETYLOXY)-16,17-(BUTYLIDENEBIS(OXY))-11-HYDROXYPREGNA-1,4-DIENE-3,20-DIONE
- (11|A,16|A)-21-(Acetyloxy)-16,17-[butylidenebis(oxy)]-11-hydroxy-pregna-1,4-diene-3,20-dione
- (11ss,16a)-21-(Acetyloxy)-16,17-[butylidenebis(oxy)]-11-hydroxy-pregna-1,4-diene-3,20-dione; 21-(Acetoxy)-16a,17a-(butylidenedioxy)-11ss-hydroxypregna-1,4-diene-3,20-dione; 16a,17-[(1RS)-Butylidenebis(oxy)]-11ss,21-dihydroxypregna-1,4-diene-3,20-dione 21-Acetate; Budesonide Imp. K (EP)
- 16.ALPHA.,17-((1RS)-BUTYLIDENEBIS(OXY))-11.BETA.,21-DIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE-21-ACETATE
- 16?,17-[(1RS)-Butylidenebis(oxy)]-11?,21-dihydroxypregna-1,4-diene-3,20-dione 21-Acetate
- 2-((6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-6a,8a-dimethyl-4-oxo-10-propyl-2,4,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-8b-yl)-2-oxoethyl acetate
- 2-[(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-9,13-dimethyl-16-oxo-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-8-yl]-2-oxoethyl acetate
- 2-[(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-Hydroxy-4a,6a-dimethyl-2-oxo-8-propyl-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl acetate
- 2-[(4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-Hydroxy-4a,6a-dimethyl-2-oxo-8-propyl-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bH,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-6b-yl]-2-oxoethyl acetate
- 21-(ACETOXY)-16.ALPHA.,17.ALPHA.-(BUTYLIDENEDIOXY)-11.BETA.-HYDROXYPREGNA-1,4-DIENE-3,20-DIONE
- 21-Acetoxy-11 beta -hydroxy-16 alpha ,17 alpha -propylmethylenedioxpregna-1,4-diene-3,20-dione